InvestLog
CAMP CAMP4 Therapeutics Corporation logo

CAMP CAMP4 Therapeutics Corporation

Healthcare
$4.51+2.50%ClosedMarket Cap: $95.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

8.45

P/S

24.35

EV/EBITDA

0.02

DCF Value

$2.92

FCF Yield

-27.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

76.2%

Operating Margin

-1322.6%

Net Margin

-2193.7%

ROE

-194.7%

ROA

-81.8%

ROIC

-58.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$1.3M$-18.3M$—
Q4 null$348.0K$-40.3M$—
FY null$3.5M$-80.4M$—
Q3 null$795.0K$-15.1M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$11.40

Target (Median)

$10.00

Target Range

$5.00 - $18.00

1 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Leerink PartnersOutperform
2026-04-02
JP MorganNeutral
2025-09-16
Piper SandlerOverweight
2025-09-15

Trading Activity

Insider Trades

View All
Tardiff Danielofficer: Chief Scientific Officer
SellFri Apr 03
Maricich Yuriofficer: Chief Medical Officer
SellFri Apr 03
Mandel-Brehm Joshdirector, officer: Chief Executive Officer
SellFri Apr 03
MacLean Michael Fdirector
SellFri Apr 03
MacLean Michael Fdirector:
SellFri Apr 03

Latest News

Canadian GoldCamps Provides Corporate & Technical Work Program UpdatesTheNewswire · Tue Apr 14

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

—

Beta

0.04

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Peers

ACRV logoACRVALXO logoALXOATYR logoATYRBMEA logoBMEAHYFT logoHYFTPMVP logoPMVPQNCX logoQNCXRPTX logoRPTXUNCY logoUNCYVXRT logoVXRT